A Process Selection Framework for Purifying Rat IgG1 Monoclonal Antibodies from Hybridoma Culture Supernatants: CaptureSelect IgG-Fc for Speed and POROS 50 HS-Capto Q for Scale.
Sep 2026· Protein Expression and Purification· Vol 244, pp.
107007
· 0 citations· 56 references
Medicine
Abstract
Efficient purification of rat-derived antibodies is an ongoing challenge in biologics development, particularly for isotypes that are difficult to capture using conventional affinity methods. Traditional Protein A/G affinity resins often exhibit limited efficiency and scalability for rat antibodies, particularly rat IgG1, which binds poorly to these ligands. Aside from efficiency and scalability concerns, broad application of affinity resins can be limited by sodium hydroxide ligand incompatibility. To address these limitations, we developed two alternative purification processes tailored to different production scales. For small-scale discovery screening, CaptureSelect IgG-Fc significantly outperformed Protein G across three rat IgG1 monoclonal antibodies, achieving monomer yields of 62.7-89.9% (compared to 32.1-43.1% for Protein G) and purities exceeding 90% in a straightforward bind-and-elute operation. For gram-scale production, we established a sanitizable multi-step process utilizing POROS 50 HS cation-exchange capture followed by Capto Q flow-through anion-exchange polishing. Design-of-experiments optimization of the Capto Q step (pH 7.4-7.6, 50-60 mM Tris-HCl) delivered over 90% monomer purity and overall process recoveries of 59.9-76.6%. ELISA assays verified antibody integrity and binding activity for both methods. Together, these results provide a practical process selection framework that expands production options for hybridoma-derived antibodies.
Antibodies can originate from various sources such as animal immunizations, patient material, DNA/RNA libraries and (AI-based) de novo design. Pre-made (e.g. synthetic) DNA libraries have substantial advantages over traditional immunization campaigns in terms of speed, cost, animal welfare, amount of required antigen a...
Sebastiaan L. Tetteroo, Chelsea Tawiah, G. Dekkers et al.· bioRxiv· 0 citations
Antibodies play essential roles in mediating interactions between the host and microbiota. Despite their importance, the specificity and functional properties of naturally occurring antibodies reactive to gut microbiota remain poorly characterized, particularly at the monoclonal level. Here, we employed Ecobody technol...
Khairil Anwar, Shota Kaneko, Itsuki Kawakita et al.· Journal of Bioscience and Bi...· 0 citations
Traditionally, enhancing the function of T cell-recruiting antibodies requires a labor-intensive two-step process: initial phage display screening for binding affinity and secondary screening for cytotoxic activity. In this study, we utilized the bispecific bivalent antibody framework 'BiBian' and combined VHH phage di...
Aruto Sugiyama, H. Nakazawa, Tomoyuki Ito et al.· New Biotechnology· 0 citations
Abstract Rapid and scalable protein binder discovery platforms are essential for accelerating therapeutic and diagnostic development. Click display is a cell-free protein display technology that covalently links nascent proteins to their encoding cDNA in a one-pot reaction within 2 h, enabling rapid in vitro selection....
Joshua D. Bryant, Yu Zeng, Monisha Yerram et al.· Protein engineering, design...· 0 citations
BACKGROUND
Planarian neoblasts are pluripotent adult stem cells responsible for whole-body regeneration, yet antibody-based tools for their specific identification and isolation remain limited. This study aimed to generate a high-affinity single-chain variable fragment (scFv) targeting TSPAN-1, a neoblast surface marke...
The generation of chicken-derived scFv antibodies targeting the FCV VP1-CDEF' region are reported, with high-affinity clones 2B2 and 2E1 are promising candidates for rapid diagnostic test development and warrant further evaluation.
Yan-Quan Wei, Yi-Han Liu, Zhen Han et al.· Frontiers in Microbiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.